bharat biotech announces successful phase-3 trial results of covaxin | made in india vaccine | wion
Published 3 years ago • 25K plays • Length 3:41Download video MP4
Download video MP3
Similar videos
-
2:54
bharat biotech releases covaxin's price ahead of india's phase 3 of vaccination | covid-19 vaccine
-
1:12
covaxin phase-3 trial will begin as second trial has successful results | india | corona vaccine
-
1:05
bharat biotech announces phase 3 results of covaxin, says it shows interim efficacy of 81%| breaking
-
2:14
bharat biotech announces covaxin's efficacy rate after final stage trials | covid-19 vaccine | news
-
2:32
‘covaxin has 81% efficacy’: bharat biotech phase 3 trial results
-
1:05
bharat biotech concludes phase 3 trial of covaxin records 77.8% efficacy rate
-
4:56
bharat biotech's covaxin shows 77.8% efficacy rate in phase 3 trial
-
3:40
covid-19 news: 70-80% decline in participants for phase3 trial of bharat biotech's covaxin
-
2:31
covaxin shows 77% efficacy in phase 3 trials, bharat biotech informs govt panel, data under review
-
10:26
covid-19 vaccine: bharat biotech releases covaxin's phase 3 trial data, claims 77.8% efficacy
-
2:42
covaxin shows interim efficacy of 81% in phase 3 results: bharat biotech
-
3:06
81% interim clinical efficacy for bharat biotech’s made-in-india covid-19 vaccine, covaxin
-
3:36
bharat biotech phase 3 results | covaxin releases their interim analysis from phase three trials
-
2:11
phase iii trials of bharat biotech's covaxin | cnbc-tv18
-
0:52
covaxin: bharat biotech granted permission to start phase-3 trials for covid-19 vaccine
-
2:23
bharat biotech enrols over 25,000 volunteers for covaxin phase 3 trial
-
1:16
covid19 vaccine | bharat biotech's covaxin shows 77.8% efficacy in phase 3 trials
-
4:50
headlines: covaxin 77.8% effective against coronavirus in phase 3 trial, says bharat biotech
-
2:55
covaxin 77.8% effective in phase 3 trial data: sources